These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 6276273)

  • 1. Intracellular "labyrinths" in acute leukaemia. Do they indicate the maturational ability of leukaemic cells?
    Lelkes G; Kelkes GY; Natonek K; Hollán SR
    Haematologia (Budap); 1981; 14(3):293-306. PubMed ID: 6276273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The mechanism of cell proliferation in acute (immature-cell) leukemia].
    Urasiński I; Kordecki H
    Acta Haematol Pol; 1977; 8(3):205-212. PubMed ID: 270271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The erythropoiesis in acute lymphoblastic leukaemia. A morphologic study.
    Sjögren U
    Lymphology; 1979 Dec; 12(4):225-7. PubMed ID: 294491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of adult acute leukemia by scanning electron microscopy and surface markers on the basis of the FAB classification (author's transl)].
    Yamada K; Okabe N; Uzuka Y
    Rinsho Ketsueki; 1982 Mar; 23(3):293-304. PubMed ID: 6955533
    [No Abstract]   [Full Text] [Related]  

  • 5. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
    Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
    Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine incorporation into leukaemic blast cells.
    Lange Wantzin G
    Biomedicine; 1979 Oct; 31(6):158-63. PubMed ID: 294296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Phi bodies in acute leukaemia.
    Cardullo Lde S; Morilla R; Catovsky D
    J Clin Pathol; 1981 Feb; 34(2):153-7. PubMed ID: 6262384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystalline inclusions in the cytoplasm and nuclei of cells of acute myeloid leukaemia.
    Pearson EC
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):311-9. PubMed ID: 2475413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell volume measurements in acute leukaemia: method and value for diagnosis and prognosis.
    Facquet-Danis J; Zittoun R; Bouchard M; Cadiou M; Bousser J; Bilski-Pasquier G
    Biomedicine; 1976 Sep; 25(8):294-8. PubMed ID: 1069593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific antibodies to viruses HL-23 and BILN in the blood plasma of patients with acute myelogenous leukaemia and with potential preleukaemia.
    Tóth FD; Kiss J; Váczi L; Madár Z; Jakó J; Rák K
    Acta Microbiol Acad Sci Hung; 1980; 27(2):147-53. PubMed ID: 6251702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lysine metabolism in acute leukemia].
    Hansz J
    Acta Haematol Pol; 1979 Oct; 10(4):237-42. PubMed ID: 295172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the Kirsten-ras proto-oncogene in human preleukaemia.
    Liu E; Hjelle B; Morgan R; Hecht F; Bishop JM
    Nature; 1987 Nov 12-18; 330(6144):186-8. PubMed ID: 3313061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of monocytic leukaemia cutis in a patient with myelodysplastic syndrome transforming to acute myeloid leukaemia.
    Perez A; Kennedy C; Standen G; Oxley J
    Clin Exp Dermatol; 2004 Sep; 29(5):497-8. PubMed ID: 15347335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
    Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
    Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light green crystals in May-Grünwald and Giemsa-stained bone marrow macrophages in patients with myeloid leukaemia.
    Stavem P; Ly B; Bjorneklett A
    Scand J Haematol; 1977 Jan; 18(1):67-72. PubMed ID: 65789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The determination of myeloid-committed stem cells in systemic disorders of myelopoiesis: implications for physiopathology, diagnosis and prognosis].
    Hinterberger W
    Acta Med Austriaca Suppl; 1981; 21():1-20. PubMed ID: 6949436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].
    Sanz Rodríguez C; Steegmann JL; Granda A; de la Cámara R; Figuera A; Arranz R; Gómez-García de Soria V; Alegre A; Fernández-Rañada JM
    Sangre (Barc); 1999 Dec; 44(6):456-63. PubMed ID: 10822760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytological features of acute leukaemia in the central region of Tunisia].
    Jmili NB; Ben Abdelaziz A; Nagara M; Mahjoub T; Ghannem H; Kortas M
    East Mediterr Health J; 2004; 10(4-5):640-7. PubMed ID: 16335657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.